SES
- Product code
- SES
- Device name
- Non-Factor Replacement Product Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 864.7298
- Medical specialty
- Hematology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
A non-factor replacement product test system is a prescription in vitro diagnostic device intended to measure non-factor replacement therapeutic products that are indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with bleeding disorders, including hemophilia, in human blood specimens to ensure appropriate therapy in accordance with the approved non-factor replacement product labeling.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN240035 | 2025-05-22 | Randox Laboratories, Ltd. | ConcizuTrace ELISA | — |
Official FDA classification page: SES
Classification and pathway per current FDA publications. Data from openFDA (CC0).